MultiCare agrees to $3.7M settlement over allegations it knowingly allowed unnecessary surgeries
fiercehealthcare - The DOJ said MultiCare had allowed a former physician to perform spinal surgery procedures at its facilities between 2019 and 2021 despite warnings from two employees and the U.S. Attorney's Office.
AI Summary: Federal investigators found that MultiCare knowingly allowed a former physician to perform unnecessary spinal surgeries despite multiple warnings, prompting a whistleblower lawsuit. In response, the health system agreed to a $3.7 million settlement to resolve the allegations and avoid further litigation.
HHS to drop 340B rebate pilot after court rulings
Ella Jeffries / beckershospitalreview - HHS will drop its 340B rebate model pilot program following two federal court rulings that blocked its implementation. The program, announced in August 2025, was challenged by the American Hospital Association, the Maine Hospital Association and four safe…
AI Summary: In a twist that no one saw coming (except the federal courts), HHS has scrapped its controversial 340B rebate pilot after two judicial rulings blocked its implementation. Providers, relieved to avoid a potential cash flow nightmare, are quietly celebrating the decision as one less bureaucratic headache to manage.
#ISC26: Bayer’s asundexian reduced ischemic strokes by 26% in Phase 3 trial
Ayisha Sharma / endpoints - Bayer shared more details from its unexpected win in a Phase 3 study testing its next-generation blood thinner for secondary stroke prevention. The factor XIa inhibitor, named asundexian, reduced the occurrence of ischemic stroke by ...
AI Summary: Bayer’s latest Phase 3 study of asundexian has shown a 26% reduction in secondary ischemic stroke risk—without an increased bleeding risk. This compelling data bolsters the drug’s prospects as a blockbuster in stroke prevention and underscores Bayer’s commitment to advancing cardiovascular therapies.
AI model reads brain MRIs in seconds, hitting up to 97.5% accuracy
medicalxpress - An AI-powered model developed at the University of Michigan can read a brain MRI and diagnose a person in seconds, a study suggests. The model detected neurological conditions with up to 97.5% accuracy and predicted how urgently a patient required treatme…
AI Summary: Researchers at the University of Michigan have unveiled an AI-powered model that reads brain MRIs in seconds with up to 97.5% accuracy. This breakthrough promises to ease radiologist workloads and dramatically speed up neurodiagnostics, potentially transforming clinical workflows in imaging.
Eikon Therapeutics Raises $381 M in IPO to Advance Live-Cell Imaging in Cancer Drug Discovery
oncodaily - Eikon Therapeutics has raised $381 million through its IPO, pricing at the top of its range in a strong sign of renewed investor appetite for biotech offerings. The South San […]
AI Summary: Eikon Therapeutics successfully raised $381 million in its IPO, reinforcing investor confidence in novel biotechnology approaches for cancer drug discovery. The fundraising milestone is expected to accelerate live‐cell imaging and other innovative oncology research initiatives.
High Consumption of Ultraprocessed Foods May Be Linked to Cancer Survivors’ Risk of Death
Kathleen Medora / aacr - PHILADELPHIA – Cancer survivors who consumed higher amounts of ultraprocessed foods as part of their diet had a significantly increased risk of both all-cause and cancer-specific death, according to a study published in Cancer Epidemiology, Biomarkers & P…
AI Summary: Recent research from a Philadelphia‐based study indicates that cancer survivors consuming high amounts of ultraprocessed foods face significantly increased risks of both overall and cancer‐specific death. Experts stress that optimizing diet post‐treatment is critical for improving long‐term outcomes.
Epic rolls out AI Charting tool
Naomi Diaz / beckershospitalreview - Epic has rolled out AI Charting, a built-in tool that listens during patient visits and drafts clinicians’ notes and suggested orders in real time. The feature is part of Epic’s expanding set of AI capabilities built directly into its software, according …
AI Summary: Epic has launched an integrated AI–powered charting tool designed to automate note–taking and suggest orders during patient visits, a strategic move aimed at reducing documentation burden and streamlining clinical workflow in a competitive ambient scribe market.
A newborn's death likely linked to the mom drinking raw milk while pregnant
go - Health officials in New Mexico have said a newborn baby died from a listeria infection likely linked to the child's mother drinking raw milk during pregnancy
AI Summary: New Mexico health officials report a tragic newborn death attributed to a listeria infection linked to the mother’s consumption of unpasteurized raw milk during pregnancy, re–igniting long–standing concerns about food safety standards and the risks involved in consuming unregulated dairy products.
HHS scraps 340B rebate pilot in win for hospitals
Emily Olsen / healthcaredive - The Trump administration agreed to drop a controversial pilot that would have allowed drugmakers to give post-sales rebates on some drugs instead of upfront discounts.
AI Summary: Federal health officials have reversed course on a highly controversial 340B rebate pilot program after federal courts blocked its implementation – a move hailed by providers as a long‐awaited relief from cash flow and administrative burdens.
Statin pills much safer than advertised, major review finds
bbc - The results, in The Lancet journal, come from trials involving more than 120,000 people comparing statins with a dummy drug or placebo.
AI Summary: Multiple large‐scale analyses have debunked the long‐held worries about statin side effects – it turns out that those pesky symptoms listed on package leaflets are no more common than when taking a placebo. In other words, patients can keep calm and lower cholesterol with confidence.
Novo Nordisk vows legal action to protect Wegovy pill
medicalxpress - Novo Nordisk said Thursday it would take legal action against a US chain offering a copycat of the new pill version of its Wegovy weight-loss drug.
AI Summary: Novo Nordisk has vowed to take legal action after discovering that competitors – including Hims & Hers – plan to market a compounded, lower‐priced version of its new Wegovy weight‐loss pill. The company is mobilizing its legal team to protect its intellectual property amid fierce market competition.
Plastic Surgeons’ Group Advises Delaying Gender-Affirming Procedures Until Age 19
Andrew Jacobs / nytimes - The organization’s latest guidance is a departure from the prevailing views of several other major medical organizations.
AI Summary: Multiple reports confirm that the American Society of Plastic Surgeons is advising that elective gender‐affirming procedures for minors be delayed until patients reach age 19. The recommendation diverges from other medical group views and aims to enhance patient safety by waiting until later adolescence for irreversible surgical interventions.
FTC deal over insulin prices forces Express Scripts to overhaul policies
Elizabeth Casolo / beckershospitalreview - The Federal Trade Commission reached a settlement with Cigna’s Express Scripts in a case over alleged inflation of insulin prices, according to a Feb. 4 agency news release. Under the settlement, Express Scripts must keep drug manufacturer compensation de…
AI Summary: Federal regulators reached a settlement with Express Scripts amid long‐standing allegations that the pharmacy benefit manager overcharged for insulin. The deal forces sweeping policy revisions to curb price inflation and protect patients from rising costs, following years of regulatory scrutiny over insulin rebate practices.
Meditech founder and EHR innovator A. Neil Pappalardo dies at 83
fiercehealthcare - Pappalardo is considered a tech pioneer with a 56-year career that started when he founded electronic health record company Meditech in 1969, a company he steered to become one of the leading EHR companies.
AI Summary: Tech pioneer A. Neil Pappalardo – the founder of Meditech whose 56‐year career revolutionized electronic health records – has passed away at 83. His contributions reshaped healthcare IT and continue to influence clinical practice worldwide.
Letters, Jan. 27, 2026: ‘A Team Canada must be assembled’ to help diversify trade
Jeffrey Morgan / calgarysun - Need to diversify I just watched a video detailing the prior commercial trading practices between Canada and the U.S. It makes me realize there is nothing more important than Canada diversifying its trade with other countries. By ‘nothing,’ I mean all pro…
AI Summary: Summit Therapeutics announced that the U.S. Food and Drug Administration has accepted its Biologics License Application for Ivonescimab—intended for patients with EGFR‑mutated non‑small cell lung cancer who have progressed after TKI therapy. The regulatory nod signals a promising step forward in targeted lung cancer treatment.
Sarbajit Mukherjee: Who Truly Benefits from Perioperative Immunotherapy in Gastric and GEJ Cancer?
oncodaily - Sarbajit Mukherjee, Chief of GI Medical Oncology at Miami Cancer Institute and Co-Chair of GI Clinical Trial Working Group at Hoosier Cancer Research Network, shared a post on LinkedIn about a recent […]
AI Summary: Multiple alerts from health authorities emphasize that the physical exertion of shoveling heavy snow in frigid conditions can spike cardiovascular risk. With reports echoing similar cautions, experts advise caution and proper pacing while clearing snow to avoid strain on the heart.
India says it has contained Nipah virus outbreak as some Asian countries ramp up health screenings
go - Indian authorities have contained a Nipah virus outbreak after confirming two cases in eastern West Bengal state
AI Summary: Indian health authorities report that a recent Nipah virus outbreak in West Bengal – marked by two confirmed cases – has been successfully contained. In response, airports and health officials have stepped up screenings to curb further spread, highlighting growing regional vigilance in controlling the outbreak.
FDA lifts hold on one of two Phase 3 gene editing studies by Intellia
Lei Lei Wu / endpoints - The FDA has allowed Intellia Therapeutics to resume one of its two pivotal trials of a gene editing therapy for transthyretin amyloidosis, which is a disease caused by misfolded proteins. Intellia
AI Summary: U.S. regulators have just cleared Intellia Therapeutics’ Phase 3 study of a gene‐editing therapy intended to treat a genetic nerve disorder, effectively rescinding a clinical hold. This development opens the door to renewed patient enrolment and further evaluation of the treatment’s safety and effectiveness.
31,000 Kaiser Permanente workers strike in California, Hawaii
Emily Olsen / healthcaredive - Kaiser workers are calling for increased staffing and wages, which the union argues haven’t kept pace with rising costs. The health system said a generous offer is already on the table.
AI Summary: Reports indicate that roughly 31,000 Kaiser Permanente employees in California and Hawaii staged a coordinated walkout over stagnant wages and challenging working conditions, spotlighting deep-seated labor issues in the healthcare industry.
CMS official defends flat Medicare Advantage rate proposal for 2027
Rebecca Pifer Parduhn / healthcaredive - Medicare director Chris Klomp said the Trump administration is “massively” in support of MA as health insurers cry foul over the meager rate update.
AI Summary: A CMS official defended the administration’s plan to freeze Medicare Advantage rate adjustments for 2027 despite industry outcry. Critics argue the flat-rate approach may hurt patient benefits while officials insist it brings consistency amid a contentious policy environment.